Sfriso Riccardo, Bongoni Anjan, Banz Yara, Klymiuk Nikolai, Wolf Eckhard, Rieben Robert
Department of Clinical Research, University of Bern; Graduate School for Cellular and Biomedical Sciences, University of Bern.
Immunology Research Centre, St. Vincent's Hospital Melbourne.
J Vis Exp. 2017 Sep 5(127):56227. doi: 10.3791/56227.
In vivo, endothelial cells are crucial for the natural anticoagulation of circulating blood. Consequently, endothelial cell activation leads to blood coagulation. This phenomenon is observed in many clinical situations, like organ transplantation in the presence of pre-formed anti-donor antibodies, including xenotransplantation, as well as in ischemia/reperfusion injury. In order to reduce animal experimentation according to the 3R standards (reduction, replacement and refinement), in vitro models to study the effect of endothelial cell activation on blood coagulation would be highly desirable. However, common flatbed systems of endothelial cell culture provide a surface-to-volume ratio of 1 - 5 cm of endothelium per mL of blood, which is not sufficient for natural, endothelial-mediated anticoagulation. Culturing endothelial cells on microcarrier beads may increase the surface-to-volume ratio to 40 - 160 cm/mL. This increased ratio is sufficient to ensure the "natural" anticoagulation of whole blood, so that the use of anticoagulants can be avoided. Here an in vitro microcarrier-based system is described to study the effects of genetic modification of porcine endothelial cells on coagulation of whole, non-anticoagulated human blood. In the described assay, primary porcine aortic endothelial cells, either wild type (WT) or transgenic for human CD46 and thrombomodulin, were grown on microcarrier beads and then exposed to freshly drawn non-anticoagulated human blood. This model allows for the measurement and quantification of cytokine release as well as activation markers of complement and coagulation in the blood plasma. In addition, imaging of activated endothelial cell and deposition of immunoglobulins, complement- and coagulation proteins on the endothelialized beads were performed by confocal microscopy. This assay can also be used to test drugs which are supposed to prevent endothelial cell activation and, thus, coagulation. On top of its potential to reduce the number of animals used for such investigations, the described assay is easy to perform and consistently reproducible.
在体内,内皮细胞对于循环血液的天然抗凝作用至关重要。因此,内皮细胞活化会导致血液凝固。这种现象在许多临床情况中都能观察到,比如存在预先形成的抗供体抗体时的器官移植,包括异种移植,以及缺血/再灌注损伤。为了根据3R标准(减少、替代和优化)减少动物实验,非常需要用于研究内皮细胞活化对血液凝固影响的体外模型。然而,常见的内皮细胞培养平板系统提供的内皮表面积与血液体积之比为每毫升血液1 - 5平方厘米的内皮,这对于天然的内皮介导的抗凝作用来说是不够的。在微载体珠上培养内皮细胞可能会将表面积与体积之比提高到40 - 160平方厘米/毫升。这种增加的比例足以确保全血的“天然”抗凝作用,从而可以避免使用抗凝剂。本文描述了一种基于微载体的体外系统,用于研究猪内皮细胞基因改造对未抗凝的全人类血液凝固的影响。在所描述的实验中,野生型(WT)或转染了人类CD46和血栓调节蛋白的原代猪主动脉内皮细胞在微载体珠上生长,然后暴露于新采集的未抗凝人类血液中。该模型能够测量和量化细胞因子释放以及血浆中补体和凝血的活化标志物。此外,通过共聚焦显微镜对活化的内皮细胞以及内皮化珠上免疫球蛋白、补体和凝血蛋白的沉积进行成像。该实验还可用于测试旨在预防内皮细胞活化从而预防凝血的药物。除了有可能减少用于此类研究的动物数量外,所描述的实验易于操作且可重复性强。